🧬Neuroscience & CNS
Companies developing treatments for neurological and psychiatric disorders including Alzheimer's, Parkinson's, and depression.
Market Cap$209.9B
1D-0.77%
Companies657
Public Cos52
SECTOR MARKET CAP
$209.9B+45669.2%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Belgium | $54.2B | UCB.VI |
| 2 |  | Japan | $35.5B | 4578.T |
| 3 |  | United States | $26.6B | BIIB |
| 4 |  | Hong Kong | $13.5B | RGC |
| 5 |  | United States | $12.8B | NBIX |
| 6 |  | Japan | $8.4B | 4523.T |
| 7 |  | United States | $8.3B | PRAX |
| 8 |  | United States | $8.0B | AXSM |
| 9 |  | United States | $7.6B | CYTK |
| 10 |  | Canada | $5.2B | XENE |
| 11 |  | Denmark | $4.6B | HLUN-B.CO |
| 12 |  | United States | $1.6B | HRMY |
| 13 |  | United States | $1.5B | AMLX |
| 14 |  | United States | $1.4B | TRVI |
| 15 |  | United States | $1.3B | BHVN |
| 16 |  | United States | $1.3B | RAPP |
| 17 |  | Germany | $1.3B | ATAI |
| 18 |  | United States | $1.2B | TSHA |
| 19 |  | Australia | $1.0B | NEU.AX |
| 20 |  | Switzerland | $1.0B | IDIA.SW |